|
 |
Michael A. Mussallem |
Rose-Hulman Institute of Technology alumnus Michael A. Mussallem, chairman and CEO of Edwards Lifesciences Corporation, has been elected to a two-year term as chairman of the board of directors of the Advanced Medical Technology Association (AdvaMed), the world's largest and most influential medical device trade association.
Mussallem (Chem. Eng., '74; Honorary Degree, '99) previously had served as chairman of AdvaMed's board committee on payment and healthcare delivery.
"I am honored to serve as AdvaMed's chairman and look forward to building on its numerous successes as the leading advocacy group for the medical technology industry," said Mussallem. "During my chairmanship, I will be dedicated first to doing what's best for patients, while also working to increase awareness of the benefits of innovation in medical technology, enhance industry ethics and strengthen relationships with key stakeholders on a global basis."
"AdvaMed is fortunate to have Mike leading the association," said Stephen J. Ubl, president and CEO of AdvaMed. "His current and previous leadership roles provide the valuable experience necessary for chairing AdvaMed. With his lengthy tenure at Edwards Lifesciences, Mike has a keen proficiency in addressing critical issues facing the medical devices industry. His role as the former chair of AdvaMed's International Committee provides an understanding of the global opportunities and challenges confronting the industry. As the outgoing chair of the Board Payment and Health Care Delivery Committee, he successfully led the industry's advocacy campaign against sweeping changes to Medicare's inpatient hospital prospective payment systems, which would have negatively impacted patient
access to advanced medical technologies. We expect AdvaMed's role as a leading voice for innovation in health care policy will continue to expand under Mike's chairmanship."
Mussallem, 55, has headed Edwards Lifesciences since it was spun-off from Baxter International Inc. and began operating as an independent, publicly traded company in April 2000. Headquartered in Irvine, Calif., Edwards Lifesciences is a world leader in products and technologies to treat advanced cardiovascular disease. Previously, he was responsible for the worldwide operations of both Baxter's cardiovascular business and its biopharmaceuticals business.
Along with his service to AdvaMed, Mussallem is a director of Advanced Medical Optics, Inc., serves on the boards of the California Healthcare Institute and OCTANe, and is a member of the University of California, Irvine, Chief Executive Roundtable.
|
